Last reviewed · How we verify
Diclofenac 50mg
At a glance
| Generic name | Diclofenac 50mg |
|---|---|
| Sponsor | University of Maryland, Baltimore |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow (PHASE4)
- Diclofenac Dose Response Study (PHASE1)
- Intramuscular Versus Rectal Diclofenac for Pain Relief After Cesarean Section in Women (PHASE4)
- The Effect of Three Different Medications on Anesthetic Success and Postoperative Pain (NA)
- Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine (PHASE4)
- Assessment of Different Medications in Modifying the Efficacy of Anesthesia in Mandibular Molars With Acute Irreversible Pulpitis (PHASE4)
- Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure (NA)
- Assessment of Safety and Efficacy of Gabapentin After Surface Ablation, a Case Control Experimental Study (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diclofenac 50mg CI brief — competitive landscape report
- Diclofenac 50mg updates RSS · CI watch RSS
- University of Maryland, Baltimore portfolio CI